PTX Pernix Therapeutics Holdings Inc.


64,387 Shares Traded
132,198 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $5.54 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-0.4%
If Intiated One Month Ago, Shorts Have Realized a Return of:0.4%
If Initiated Five Days ago, Shorts Have Realized a Return of:-5.04%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 80.07%
Short Interest2.22 million
Float2.77 million
Short Ratio15.27
Market Cap$29.49 million
Market Maker ActivityDaily Short Volume


Premarket Gainers as of 9:05 am (02/20/2018) (SeekingAlpha)
After Hours Gainers / Losers (2/16/2018) (SeekingAlpha)
Wall Street Breakfast: Infrastructure Details Coming Today (SeekingAlpha)
OxyContin maker stops promoting opioids (SeekingAlpha)
Pernix announces patent litigation settlement agreement with Actavis concerning Zohydro ER (SeekingAlpha)
Your Daily Pharma Scoop: Lipocine Ahead Of Ad Com, Ohr's MAKO Study Fails, Zafgen Provides Update (SeekingAlpha)
Pernix shakes up commercial business, cuts 22% of workforce; shares up 3% premarket (SeekingAlpha)
Cost of U.S. opioid epidemic tops $500B (SeekingAlpha)
Pernix Therapeutics' (PTX) CEO John Sedor on Q3 2017 Results - Earnings Call Transcript (SeekingAlpha)
Pernix Therapeutics reports Q3 results (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 15.5%

Earnings Stats

PE Ratio -0.65
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $3.22
50 Day Moving Average $2.47
52 Week High $7.15
52 Week Low $2

Data provided for free by IEX. Questions? Read the FAQ